Stock CLXP.F CYBIN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cybin Inc. OTC Markets

Equities

CLXP.F

CA23256X1006

End-of-day quote OTC Markets
Other stock markets
 06:00:00 2021-08-31 pm EDT 		5-day change 1st Jan Change
2.63 CAD -6.07% Intraday chart for Cybin Inc. +17.41% +76.51%
Jun. 26 Cybin Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Jun. 11 Cybin Inc. Appoints Atul R. Mahableshwarkar as Senior Vice President, Clinical Development CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 119B
ARGENX SE Stock argenx SE
 27.95B -
BIONTECH SE Stock BioNTech SE
 20.5B -
GENMAB A/S Stock Genmab A/S
 17.12B
  1. Stock Market
  2. Equities
  3. CYBN Stock
  4. CLXP.F Stock
  5. Charts Cybin Inc.
  6. Sector Chart